MedPath

PillCam SBC System Functionality in Established and Suspected IBD Patients

Not Applicable
Completed
Conditions
Crohn's Disease
Chronic Inflammatory Small Bowel Disease
Interventions
Device: PillCam SBC system
Registration Number
NCT02742714
Lead Sponsor
Medtronic - MITG
Brief Summary

This clinical study is designed to evaluate the PillCam SBC system performance in 50 established or suspected inflammatory bowel disease (IBD) patients by visualizing and assessing their small and large bowel.

Detailed Description

The PillCam SBC system to be tested in this study, is a new system composed of capsule, Data recorder and a new software Pillcam Desktop Software (version 9.0). The main features of the SBC capsule are panoramic field of view and adaptive frame rate customized for complete coverage of both small bowel and colonic mucosa.

Fifty established and suspected IBD patients (at least half of them with established crohn disease (CD)) with active or quiescent disease activity, aged 18 years and up, with no symptomatic stricture or known obstruction that would prevent capsule passage will be enrolled in up to 6 medical sites in Israel and Europe.

Patients will undergo bowel prep, followed by a PillCam SBC capsule examination. Patency capsule may precede PillCam SBC ingestion according to physician discretion.

The PillCam Software videos will be evaluated by local site reader following a Subjective Assessment Form fulfillment.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
54
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
PillCam SBCPillCam SBC systemThe PillCam SBC system to be tested in this study, is a new system composed of capsule, Data recorder and a new software Pillcam Desktop Software (version 9.0). The main features of the SBC capsule are panoramic field of view and adaptive frame rate customized for complete coverage of both small bowel and colonic mucosa.
Primary Outcome Measures
NameTimeMethod
Successful SBC procedure in terms of video creation and report generation per training instructions4 weeks

Success procedures are being measured. Only if both video and report will be created it will be defined as success.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (5)

Hospital de Navarra

🇪🇸

Pamplona, Spain

Fondazione Policlinico Universitario Agostino Gemelli

🇮🇹

Rome, Italy

The Tel-Aviv Sourasky Medical Center

🇮🇱

Tel-Aviv, Israel

Sheba Medical Center

🇮🇱

Ramat-Gan, Israel

Shaare Zedek Medical Center

🇮🇱

Jerusalem, Israel

© Copyright 2025. All Rights Reserved by MedPath